EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development, Optimization, and Physicochemical Characterization of Fluorescent Carbon Dot‐ Ginkgo biloba Extract Co‐Loaded Niosomes for Future Neurological Disease‐Relevant Evaluation

Yasaman Mohammadi iD, Mohammad Saied Salehi, Ehsan Heidari, Mina Ebrahimi iD, Nahid Ashjazadeh iD

CNS Neuroscience & Therapeutics · 2026-11 · 32 (11)

DOI: 10.1002/cns.71230 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 01.11.2026. Verfasst von Yasaman Mohammadi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Neurology Research Center of Shiraz, University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Liposomes, Plant Extracts, Carbon Quantum Dots. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alzheimer's disease (AD) is one of the major neurodegenerative diseases that affect the human brain and lead to memory loss. The present approaches to disease management have been relatively poor; the therapies provided do not arrest the disease process. This study aimed to develop and optimize dual‐loaded niosomes containing Ginkgo biloba extract and CDOTs and to evaluate their physicochemical properties, formulation‐level fluorescence, in vitro release, and preliminary cytocompatibility. The study did not assess blood–brain barrier transport, neuronal effects, Alzheimer's disease‐specific mechanisms, or in vivo therapeutic efficacy.

Results

Niosomes were prepared based on non‐ionic surfactants and cholesterol for the encapsulation of Ginkgo and CDOTs. The response surface methodology (RSM) was used to optimize niosomal formulations through a Box–Behnken design. The formulations were evaluated for vesicle size, entrapment efficiency, and release profile. Field Emission Scanning Electron Microscopy (FESEM) research indicated that the average diameters of the free niosomes and CDOT@Ginkgo@Niosomes were 69.56 nm and 72.19 nm, respectively. HFF cell viability remained high at lower concentrations, whereas significant reductions in viability were observed at 10 and 50 μg/mL after 48 h, indicating concentration‐dependent cytocompatibility. The formulation exhibited acceptable preliminary cytocompatibility at lower concentrations, whereas reduced viability was observed at higher concentrations. For both CDOT and Ginkgo, CDOT@Ginkgo@Niosomes showed a delayed release profile over 72 h, with near‐complete release observed at the final time point.

Conclusions

CDOT@Ginkgo@Niosomes showed successful co‐loading, preserved formulation‐level fluorescence, delayed release, and acceptable cytocompatibility at lower concentrations in HFF cells. These findings support further formulation optimization and subsequent evaluation in disease‐relevant neuronal, blood–brain barrier, and in vivo models. The present results do not demonstrate neuroprotection, diagnostic performance, blood–brain barrier transport, or the prevention or treatment of neurodegenerative disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiposomesPlant ExtractsCarbon Quantum DotsGinkgo bilobaHumansAnimalsGinkgo ExtractCell SurvivalParticle Size

Stichwörter der Autor:innen

Ginkgo bilobaAlzheimer's diseaseCDOTsbioavailabilitydrug deliveryniosomes

Substanzen

LiposomesPlant ExtractsGinkgo biloba extractGinkgo Extract

Autor:innen und Institutionen

  • Clinical Neurology Research Center of Shiraz, University of Medical Sciences, Shiraz, Iran.
  • School of Graduate Studies, Joint Ph.D. Program in Biomedical Engineering, Rutgers, The State University of New Jersey, Newark, New Jersey, USA.
  • Department of Pharmacology and Toxicology, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran.

ORCID-Profile: Yasaman Mohammadi, Mina Ebrahimi, Nahid Ashjazadeh

Zitieren

APA

Mohammadi, Y., Salehi, M. S., Heidari, E., Ebrahimi, M., & Ashjazadeh, N. (2026). Development, Optimization, and Physicochemical Characterization of Fluorescent Carbon Dot‐ Ginkgo biloba Extract Co‐Loaded Niosomes for Future Neurological Disease‐Relevant Evaluation. CNS Neuroscience & Therapeutics, 32(11). https://doi.org/10.1002/cns.71230

Vancouver

Mohammadi Y, Salehi MS, Heidari E, Ebrahimi M, Ashjazadeh N. Development, Optimization, and Physicochemical Characterization of Fluorescent Carbon Dot‐ Ginkgo biloba Extract Co‐Loaded Niosomes for Future Neurological Disease‐Relevant Evaluation. CNS Neuroscience & Therapeutics. 2026;32(11). doi:10.1002/cns.71230

BibTeX
@article{Mohammadi2026,
  author = {Mohammadi, Yasaman and Salehi, Mohammad Saied and Heidari, Ehsan and Ebrahimi, Mina and Ashjazadeh, Nahid},
  title = {Development, Optimization, and Physicochemical Characterization of Fluorescent Carbon Dot‐ Ginkgo biloba Extract Co‐Loaded Niosomes for Future Neurological Disease‐Relevant Evaluation},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2026},
  volume = {32},
  number = {11},
  doi = {10.1002/cns.71230}
}
Kostenlos starten →